Tarsus Pharmaceuticals, Inc. TARS Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.
The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tarsus Pharmaceuticals, Inc.'s short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tarsus Pharmaceuticals, Inc.'s short-term investments?
- Tarsus Pharmaceuticals, Inc. (TARS) reported short-term investments of $286.54M in Q1 2026.
- How has Tarsus Pharmaceuticals, Inc.'s short-term investments changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s short-term investments increased by 23.4% year-over-year, from $232.13M to $286.54M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.